Other substances

Pseudoephedrine

A phenylamine sympathomimetic agent.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

Supporting references

Contradictory references

AI-suggested references

Clinical trials

General information

Pseudoephedrine on PubChem

Marketed as

ACUNASO; AFRINOL; BENYLIN DECONGESTANT; CENAFED; DECOFED; DIMETAPP DECONGESTANT; ELTOR 120; GENAPHED; MAXENAL; MYFEDRINE; NEODURASINA; NOVAFED; ROBIDRINE; SUDAFED DECONGESTANT; SUDOGEST

C[C@@H]([C@H](C1=CC=CC=C1)O)NC

Supporting references

Link	Tested on	Impact factor	Notes	Publication date
Dual Targeting of 3CLpro and PLpro of SARS-CoV-2: A Novel Structure-Based Design Approach to treat COVID-19 3CLpro RdRpol Small molecule In silico	in silico		Predicted to bind both the SARS-CoV-2 RNA-dependent RNA polymerase and 3C-like protease.	Dec/10/2020

AI-suggested references

Link	Publication date
Network bioinformatics analysis provides insight into drug repurposing for COVID-19.	Mar/30/2021
Mechanism deconvolution of Qing Fei Pai Du decoction for treatment of Coronavirus Disease 2019 (COVID-19) by label-free integrative pharmacology assays.	Aug/03/2021
Screening and evaluation of anti-SARS-CoV-2 components from Ephedra sinica by ACE2/CMC-HPLC-IT-TOF-MS approach	Feb/19/2021
Pseudoephedrine and its derivatives antagonize wild and mutated severe acute respiratory syndrome-CoV-2 viruses through blocking virus invasion and antiinflammatory effect	Sep/01/2021

Export (.csv)